These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24045777)

  • 21. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
    Connolly AM; Schierbecker J; Renna R; Florence J
    Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prednisone 10 days on/10 days off in patients with Duchenne muscular dystrophy.
    Straathof CS; Overweg-Plandsoen WC; van den Burg GJ; van der Kooi AJ; Verschuuren JJ; de Groot IJ
    J Neurol; 2009 May; 256(5):768-73. PubMed ID: 19306039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy.
    Vry J; Schubert IJ; Semler O; Haug V; Schönau E; Kirschner J
    Eur J Paediatr Neurol; 2014 Mar; 18(2):140-9. PubMed ID: 24157400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekend high-dosage prednisone: a new option for treatment of Duchenne muscular dystrophy.
    Moxley RT; Pandya S
    Neurology; 2011 Aug; 77(5):416-7. PubMed ID: 21753162
    [No Abstract]   [Full Text] [Related]  

  • 25. [Guideline on the use of corticosteroids in Duchenne muscular dystrophy from paediatric neurologists, neurologists and rehabilitation physicians].
    de Groot IJ
    Ned Tijdschr Geneeskd; 2006 Mar; 150(12):684-5. PubMed ID: 16613254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy.
    Parreira SL; Resende MB; Della Corte Peduto M; Marie SK; Carvalho MS; Reed UC
    Arq Neuropsiquiatr; 2007 Jun; 65(2A):245-50. PubMed ID: 17607422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
    Bello L; Gordish-Dressman H; Morgenroth LP; Henricson EK; Duong T; Hoffman EP; Cnaan A; McDonald CM;
    Neurology; 2015 Sep; 85(12):1048-55. PubMed ID: 26311750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prednisone therapy in Becker's muscular dystrophy.
    Johnsen SD
    J Child Neurol; 2001 Nov; 16(11):870-1. PubMed ID: 11732779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.
    Reitter B
    Brain Dev; 1995; 17 Suppl():39-43. PubMed ID: 8882570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy.
    Hibaoui Y; Reutenauer-Patte J; Patthey-Vuadens O; Ruegg UT; Dorchies OM
    J Pineal Res; 2011 Sep; 51(2):163-71. PubMed ID: 21486366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.
    Ricotti V; Ridout DA; Scott E; Quinlivan R; Robb SA; Manzur AY; Muntoni F;
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):698-705. PubMed ID: 23250964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
    Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
    N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial.
    Buyse GM; Goemans N; van den Hauwe M; Thijs D; de Groot IJ; Schara U; Ceulemans B; Meier T; Mertens L
    Neuromuscul Disord; 2011 Jun; 21(6):396-405. PubMed ID: 21435876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisone for Duchenne muscular dystrophy.
    Dubowitz V
    Lancet Neurol; 2005 May; 4(5):264. PubMed ID: 15847833
    [No Abstract]   [Full Text] [Related]  

  • 37. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.
    Söderpalm AC; Magnusson P; Ahlander AC; Karlsson J; Kroksmark AK; Tulinius M; Swolin-Eide D
    Neuromuscul Disord; 2007 Dec; 17(11-12):919-28. PubMed ID: 17627820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
    Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
    J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole body vibration therapy in patients with Duchenne muscular dystrophy--a prospective observational study.
    Söderpalm AC; Kroksmark AK; Magnusson P; Karlsson J; Tulinius M; Swolin-Eide D
    J Musculoskelet Neuronal Interact; 2013 Mar; 13(1):13-8. PubMed ID: 23445910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.
    Quattrocelli M; Barefield DY; Warner JL; Vo AH; Hadhazy M; Earley JU; Demonbreun AR; McNally EM
    J Clin Invest; 2017 Jun; 127(6):2418-2432. PubMed ID: 28481224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.